CID 169501959

Bilastine metabolite-glucuronide

Structural Information

Molecular Formula
C22H31N3O7
SMILES
CCOCCN1C2=CC=CC=C2N=C1C3CCN(CC3)C4C(C(C(C(O4)C(=O)O)O)O)O
InChI
InChI=1S/C22H31N3O7/c1-2-31-12-11-25-15-6-4-3-5-14(15)23-20(25)13-7-9-24(10-8-13)21-18(28)16(26)17(27)19(32-21)22(29)30/h3-6,13,16-19,21,26-28H,2,7-12H2,1H3,(H,29,30)
InChIKey
KUMKWWIRJWVNFQ-UHFFFAOYSA-N
Compound name
6-[4-[1-(2-ethoxyethyl)benzimidazol-2-yl]piperidin-1-yl]-3,4,5-trihydroxyoxane-2-carboxylic acid
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

449.2162 Da
Monoisotopic Mass

-2.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 450.22348 206.8
[M+Na]+ 472.20542 210.3
[M-H]- 448.20892 208.6
[M+NH4]+ 467.25002 210.0
[M+K]+ 488.17936 207.0
[M+H-H2O]+ 432.21346 197.1
[M+HCOO]- 494.21440 212.2
[M+CH3COO]- 508.23005 225.5
[M+Na-2H]- 470.19087 201.9
[M]+ 449.21565 205.0
[M]- 449.21675 205.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.